
New Large-Scale Meta-Analysis Demonstrates Strong Prognostic Performance of Myriad’s Prolaris® Biopsy Test in Localized Prostate Cancer
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQdlJqMUIwZm9pYlNpM2tMS05iRk5qYm5FcW41ckdISFR5YUFnS1BXZmFEYkVNQ19GMEQzZm0zS2Faal8za3NaT0o0NFFoT3lJSFVjZmJsUWNhdnZyRHdTU0xILXlWVkhVS1VRU2tLbll0MGU5NlRJQWV3VUlVY0ZTUGR1bUtkLWNpWFFqUGtyS3VHX0VpNUJQUXE5R1ViOHRo?oc=5" target="_blank">New Large-Scale Meta-Analysis Demonstrates Strong Prognostic Performance of Myriad’s Prolaris® Biopsy Test in Localized Prostate Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Yahoo Finance</font>
